Disc Medicine, Inc. SEC filings IRON

Disc Medicine, Inc. has 778 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Disc Medicine, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 18, 2026
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 11, 2025
DEF 14A Proxy statement May 1, 2024 Jun 12, 2024
DEFA14A Additional proxy material May 1, 2024 —
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 Jun 9, 2023
DEFA14A Additional proxy material Aug 17, 2021 —
DEF 14A Proxy statement Aug 17, 2021 Sep 29, 2021

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRON (Nasdaq)
Fiscal year ends
December 31
Headquarters
Watertown, MA
SEC filer status
Large accelerated filer
SEC CIK
1816736
Former names
Gemini Therapeutics, Inc. /DE (until Dec 28, 2022); FS Development Corp. (until Feb 8, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.